Capecross Veterinary Services CC
  • Home
  • About us
  • Find a practice
    • CapeCross Jeffreys Bay
    • CapeCross Oudebosch
    • CapeCross Cradock
    • CapeCross Volksrust
    • CapeCross Head Office
  • CapeCross4Vets
  • Ani-Mall Online Shop
  • Vacancies
  • Animal Info
  • Contact Us
  1. Horses
  2. Vaccines
  1. Horses
Equilis Prequenza (Single) / Prequenza-TE (Single)

Equilis Prequenza (Single) / Prequenza-TE (Single)

From R 218.80
From R 251.62
Select Volume
  • Prequenza
  • Prequenza-TE
Quantity
dose
Brand:
  • CapeCross
  • Description
  • Enquiry

Indicated for the active immunisation of healthy horses and ponies against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection

Equilis Prequenza

COMPOSITION:
EQUILIS® PREQUENZA is a vaccine suspension containing per 1ml:
• Purified haemagglutinin/neuraminidase subunits from equine influenza viruses:
- A/equine-1/Prague/1/56 100 AU*
- A/equine-2/Newmarket/1/93 50 AU
- A/equine-2/Newmarket/2/93 50 AU
• Purified saponin (adjuvant) 375 μg
*antigenic units

WARNINGS:
Vaccinate healthy animals only. A transient swelling may occur after vaccination regressing within 2 days. In some cases fever may occur after vaccination. Avoid intravenous injection.

DOSAGE:
Intramuscular injection of one dose (1 ml) per anima

VACCINATION SCHEDULE:
Basic Vaccination course: All horses not previously vaccinated should receive two vaccinations of one dose with a four week interval. Foals should be vaccinated from the age of six months.
Revaccination: The first revaccination (third dose) is given five months after the basic vaccination course. Revaccination, at 12 month intervals is recommended to maintain immunity levels against equine influenza. Local regulations should be adhered to.

PREGNANCY AND LACTATION:
Can be used in pregnant mares

PRESENTATION:
10 x 1 ml pre-filled syringe with peel-off labels

Equilis Prequenza-TE

For the active immunisation of healthy horses and ponies against equine influenza

INDICATIONS:  It reduces the severity and duration of clinical signs and reduces the amount and duration of viral shedding after infection. It is also indicated for the active
immunisation against tetanus to prevent disease and mortality.

COMPOSITION:
EQUILIS® PREQUENZA-TE is a vaccine suspension containing per 1ml:
• Purified haemagglutinin/neuraminidase subunits from equine influenza viruses:
- A/equine-1/Prague/1/56 100 AU*
- A/equine-2/Newmarket/1/93 50 AU
- A/equine-2/Newmarket/2/93 50 AU
• Tetanus toxoid 40 Lf**
• Purified saponin (adjuvant) 375 μg
*antigenic units **flocculation units

WARNINGS:
Vaccinate healthy animals only. A transient swelling may occur after vaccination regressing within 2 days. In some cases fever may occur after vaccination. Avoid intravenous injection.

DOSAGE:
Intramuscular injection of one dose (1 ml) per animal.

VACCINATION SCHEDULE
Influenza - Basic vaccination course: All horses not previously vaccinated should receive two vaccinations of one dose with a four week interval. Foals should be vaccinated from the age of six months.
Tetanus - Basic vaccination course: All horses not previously vaccinated should receive two vaccinations of one dose with a four week interval. The first revaccination for tetanus can be given 17 months after the basic vaccination course. Can be used in pregnant
mares.

PRESENTATION
10 x 1 ml pre-filled syringes with peel-off labels

Please note that purchasing this product you agree to our TERMS AND CONDITIONS, DELIVERY AND RETURN POLICY and our PRIVACY POLICY.

Return to Ani-Mall

Quote for discounted bulk purchases/enquiry

When ordering Bravecto, state your shelter of choice in the Delivery instructions during checkout to win big!

Please Note

The Express Delivery option MUST be selected during checkout for all vaccine orders.

Please Note

The Express Delivery option MUST be selected during checkout for all vaccine orders.

Rate Our Service!

Please rate our service by clicking here. We appreciate all feedback, good or bad.

Media release on Ivermectin: Please read here.

Shopping cart

Modal title

Sign up for our newsletter

  Please enter your email or mobile number (or both)